Combined cardiac and lung volume reduction surgery.

Area of Science:

• Cardiothoracic Surgery
• Pulmonary Medicine
• Cardiology

Background:

• Severe emphysema frequently coexists with coronary artery disease and valvular heart disease.
• Patients considered for lung volume reduction surgery (LVRS) may present with significant cardiac comorbidities.
• There is a historical reluctance among thoracic and cardiac surgeons to operate on patients with combined severe cardiopulmonary disease.

Purpose of the Study:

• To review the existing evidence on combined cardiac surgery and LVRS.
• To determine the optimal management strategy for patients with severe emphysema and operable cardiac conditions.
• To address the challenges of surgical intervention in patients with combined severe emphysema and cardiac disease.

Main Methods:

• Literature review of studies on combined cardiac surgery and LVRS.
• Analysis of evidence regarding patient selection and surgical outcomes.
• Synthesis of data to identify best practices for managing complex cardiopulmonary patients.

Main Results:

• Data on combined procedures is limited, highlighting a gap in evidence.
• Successful outcomes are possible with careful patient selection and multidisciplinary collaboration.
• Risk stratification and tailored surgical approaches are crucial for managing these complex cases.

Conclusions:

• Combined cardiac surgery and LVRS is a viable option for carefully selected patients.
• Multidisciplinary teams are essential for optimizing outcomes in patients with severe emphysema and cardiac disease.
• Further research is needed to establish definitive guidelines for combined surgical interventions.